To get a broad view of the influence of FSH on the ovarian cancer, immunohistochemistry (IHC) of FSH receptor (FSHR) was performed on tissue microarray (TMA) of ovarian tumors derived from 160 ovarian cancer patients. This evidence concerns the gene BRD2 and ovarian neoplasm.